The candidate will play a critical role in building and leading a high-performing team that accelerates AstraZeneca’s emerging Cell Therapy modalities portfolio.
Base: $108,473.60 - $162,710.40; Bonus/Equity: short-term incentive bonus opportunity, equity-based long-term incentive program; Benefits: qualified retirement program [401(k) plan], paid vacation and holidays, paid leaves, health benefits
Must-have
Nice-to-have
Not specified